Literature DB >> 21286587

New drugs for epilepsy: a review.

S Verret.   

Abstract

Four relatively new drugs used as symptomatic treatment against epileptic seizures-carbamazepine (Tegretol), valproic acid (Depakene), clonazepam (Rivotril) and nitrazepam (Mogadon)-are reviewed from the standpoint of pharmacokinetic parameters, clinical indication, toxicity and practical use.

Entities:  

Year:  1983        PMID： 21286587      PMCID： PMC2153542     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  7 in total

1.  Renal computed tomography is abnormal in pyelonephritis.

Authors:  C H June; M D Browning; R S Pyatt
Journal:  Lancet       Date:  1982-07-10       Impact factor: 79.321

2.  Carbamazepine does not prevent febrile seizures in phenobarbital failures.

Authors:  P R Camfield; C S Camfield; J A Tibbles
Journal:  Neurology       Date:  1982-03       Impact factor: 9.910

3.  Effectiveness of acetazolamide in the treatment of carbamazepine-resistant epilepsy in children.

Authors:  W I Forsythe; J R Owens; C Toothill
Journal:  Dev Med Child Neurol       Date:  1981-12       Impact factor: 5.449

4.  Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.

Authors:  R A Shakir; R H Johnson; D G Lambie; I D Melville; R N Nanda
Journal:  Epilepsia       Date:  1981-02       Impact factor: 5.864

5.  Monotherapy or polytherapy for epilepsy?

Authors:  E H Reynolds; S D Shorvon
Journal:  Epilepsia       Date:  1981-02       Impact factor: 5.864

6.  Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients.

Authors:  J L Herranz; R Arteaga; J A Armijo
Journal:  Epilepsia       Date:  1982-04       Impact factor: 5.864

7.  Clonazepam (Rivotril) and carbamazepine (Tegretol) in psychomotor epilepsy: a randomized multicenter trial.

Authors:  B Mikkelsen; P Berggreen; P Joensen; O Kristensen; O Køhler; B O Mikkelsen
Journal:  Epilepsia       Date:  1981-08       Impact factor: 5.864
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.